|
Volumn 22, Issue 4, 2002, Pages 2137-2145
|
Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40)
a a a a a a a a a a |
Author keywords
BRM; Cancer therapy; Circulating dendritic cells; Immunostimulation; OK432; Propionibacterium avidum KP 40
|
Indexed keywords
BIOLOGICAL RESPONSE MODIFIER;
GLYCOPROTEIN P 15095;
IMMUNOMODULATING AGENT;
KP 40;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
PICIBANIL;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BONE MARROW CELL;
CANCER IMMUNOTHERAPY;
CELL ACTIVITY;
CELL ADHESION;
CELL ISOLATION;
CELL LINEAGE;
CELL TYPE;
CONTROLLED STUDY;
CORYNEBACTERIUM AVIDUM;
CYTOKINE PRODUCTION;
DENDRITIC CELL;
HEAT TOLERANCE;
HUMAN;
HUMAN CELL;
IMMUNOMODULATION;
MAJOR HISTOCOMPATIBILITY COMPLEX;
PERIPHERAL CIRCULATION;
PRIORITY JOURNAL;
PROPIONIBACTERIACEAE;
STREPTOCOCCUS;
VACCINATION;
VACCINE PRODUCTION;
ADJUVANTS, IMMUNOLOGIC;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
CELLS, CULTURED;
DENDRITES;
FLOW CYTOMETRY;
HUMANS;
PICIBANIL;
VACCINES, INACTIVATED;
|
EID: 0036331932
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (30)
|